TRANSGENOMIC is a global biotechnology company advancing personalized medicine in oncology and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD PCR, which enables use of liquid biopsies for mutation detection. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies. Transgenomic s diagnostic technologies are designed to improve medical diagnoses and patient outcomes..
Quote | Precipio Inc. (NASDAQ:PRPO)
Last: | $6.70 |
---|---|
Change Percent: | 0.0% |
Open: | $6.1169 |
Close: | $6.70 |
High: | $6.7 |
Low: | $6.0101 |
Volume: | 10,183 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Precipio Inc. (NASDAQ:PRPO)
NEW HAVEN, Conn., March 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its year end 2023 corporate update call on April 1 st , 2024 at 5:00 PM ET. The call will include updates on all of the company’s current co...
NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for the full year of 2023, its unaudited revenues have grown from $9.4M in 2022 to $15.2M in 2023, an increase of 60% year over year. Both ...
Message Board Posts | Precipio Inc. (NASDAQ:PRPO)
Subject | By | Source | When |
---|---|---|---|
after having sold all my shares up to | PennyStockTrader2 | investorshub | 04/06/2023 6:13:31 PM |
whytestocks: $TBIO News Article - Telesis Bio Releases BioXp Select Kits to Enable DNA Amplification | whytestocks | investorshangout | 03/31/2023 2:30:51 PM |
whytestocks: $TBIO News Article - Telesis Bio to Present at Festival of Biologics Conference | whytestocks | investorshangout | 03/16/2023 12:10:56 PM |
whytestocks: $TBIO News Article - Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial | whytestocks | investorshangout | 03/09/2023 9:35:46 PM |
znewcar1: $PRPO ML=LL.47 HOD.7733 nice curl. | znewcar1 | investorshangout | 01/17/2023 4:02:50 AM |
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., March 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), will be hosting its ye...
NEW HAVEN, Conn., March 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its year end 2023 corporate update call on April 1 st , 2024 at 5:00 PM ET. The call will include updates on all of the company’s current co...
NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for the full year of 2023, its unaudited revenues have grown from $9.4M in 2022 to $15.2M in 2023, an increase of 60% year over year. Both ...